1 completed, 1 not yet recruiting, 1 terminated. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 1, Not yet recruiting 1, Terminated 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow Achondroplasia: new trials by email Literature Review of Achondroplasia trials Research Report on Achondroplasia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of ABSK061 to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy in Children With Achondroplasia ABSK061 - Achondroplasia | Phase 1 / Phase 2 | Not yet recruiting | Abbisko Therapeutics Co, Ltd | 110 | 2025-12-10 | 2025-12-22 |
| Bioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy Participants BMN 111 administration via Injector Pen, BMN 111 administration via vial and syringe - Achondroplasia | Phase 1 | Terminated | BioMarin Pharmaceutical | 36 | 2023-03-15 | 2023-10-12 |
| A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers BMN 111, Normal Saline - Achondroplasia | Phase 1 | Completed | BioMarin Pharmaceutical | 74 | 2012-02-01 | 2012-06-11 |
Bone Diseases (3) · Bone Diseases, Developmental (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Dwarfism (3) · Genetic Diseases, Inborn (3) · Musculoskeletal Diseases (3) · Osteochondrodysplasias (3)
Saline Solution (1) · Syringes (1) · vosoritide (1)
BioMarin Pharmaceutical (2) · Abbisko Therapeutics Co, Ltd (1)
United States (2) · China (1)
Shuqi Zeng (1)